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Abstract
OBJECTIVE: To explore the function of Tangnai-
kang (TNK) in the prevention and treatment of re-
nal interstitial fibrosis through transdifferentiation
of the human renal tubular epithelial cell line HK-2
inducedbytransforminggrowthfactor-β1 (TGF-β1).
METHODS: HK-2 cells cultured in dulbecco's modi-
fied eagle medium/F12 (1∶1) with 10% fetal calf se-
rum were divided into six groups: blank control
group, TGF-β1 group (TGF-β1 10 ng/mL), serum con-
trol group (TGF-β1 10 ng/mL + 10% serum), treat-
ment group 1 (TGF-β1 10 ng/mL+5% TNK serum),
treatment group 2 (TGF-β1 10 ng/mL+10% TNK se-
rum), and treatment group 3 (TGF-β1 10 ng/mL +
20% TNK serum). Cell proliferation was detected by
4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide assay. Expression of α-smooth muscle ac-
tin (α-SMA) and E-cadherin were observed by im-
munohistochemical assay. The contents of collagen
I (Col I), collagen III (Col III), and fibronectin (FN) in
the culture medium supernatant were detected by
ELISA.
RESULTS: E-cadherin was expressed and α-SMA
was not expressed in normal HK-2 cells. In HK-2
cells cultured with TGF-β1, α-SMA expression signifi-
cantly increased, HK-2 cells significantly proliferat-
ed, and secretion of Col I, Col III, and FN significantly
increased compared with the blank control group
(all P<0.05). In the HK-2 cells cultured with TGF-β1
and TNK serum, the expression of α-SMA signifi-
cantly decreased, the expression of E-cadherin sig-
nificantly increased, and the cell proliferation and
the secretion of Col I, Col III and FN were significant-
ly inhibited compared with the TGF-β1 group (all P<
0.05).
CONCLUSION: TNK can inhibit cell proliferation
and reduce secretion of Col I, Col III, and FN. This in-
dicates that TNK can inhibit transdifferentiation of
human renal tubular epithelial cells induced by
TGF-β1, with the effect of preventing and treating
renal interstitial fibrosis.
© 2013 JTCM. All rights reserved.
Key words: Transforming growth factor beta1; Epi-
thelial cells; Cell proliferation; Cell Transdifferentia-
tion; Tangnaikang
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INTRODUCTION
Diabetic nephropathy (DN) is one of the most com-
monly encountered chronic microvascular complica-
tions of diabetes, severely threatening diabetic patients'
quality of life and health. Pathogenesis of DN is not
yet clear. In the past, renal function was thought to be
tied to glomerular lesions. However, recent studies
have found that the degree of renal tubular lesion and
renal interstitial fibrosis are more closely correlated
with renal function. Therefore, more attention is being
paid to the mechanism of renal interstitial fibrosis in
the development of DN.1
Tangnaikang (TNK) is a prescription created by Prof.
Tonghua Liu at Beijing University of Traditional Chi-
nese Medicine, and is used clinically for treatment of
diabetes. It is composed of Renshen (Radix Ginseng),
Nüzhenzi (Fructus Ligustri Lucidi), Xiakucao (Spica
Prunellae Vulgaris), Sanbaicao (Herba Saururi), and
Fanshiliuye (Folium Eacalypti Robustae). Tangnaikang
has completed stage I and II clinical tests, with a good
research basis. Previous studies indicated that Tangnai-
kang mainly regulates glucose metabolism in the dia-
betic mouse by increasing the insulin sensitivity index,
reducing insulin resistance, promoting the repair and
reproduction of islet β-cells, and regulating abnormal
fat metabolism.2-4 Recently, our research5 has found
that Tangnaikang can decrease the amount of protein
in the urine of diabetic GK rats, indicating that it has a
certain therapeutic effect on the production and devel-
opment of DN. In the present study, we investigated
the effect of Tangnaikang on transforming growth fac-
tor-β1 (TGF-β1)-induced transdifferentiation of hu-
man renal tubular epithelial HK-2 cells to further
probe its effects on renal interstitial fibrosis and its rela-
tion to DN.
MATERIALS ANDMETHODS
Cell strain
Human renal tubular epithelial cells (HK-2) were pur-
chased from the Experimental Center of Lanzhou Uni-
versity.
Animals
Twenty-four male Wistar rats, weighing (200 ± 20) g,
SPF grade, were supplied by the Animal Center of
Gansu Traditional Chinese Medicine College, license
No. SCXK (Gan) 2004-0006.
Drugs and reagents
The Dulbecco's Modified Eagle Medium and Ham's
F-12 (DMEM/F12) (1∶1) cell culture medium was
produced by Invitrogen (Carlsbad, CA, USA). Fetal
calf serum was from Hyclone (Logan, UT, USA).
EDTA and trypsin, were from Amresco Company (So-
lon, OH, USA). Enzyme-linked immuno sorbent assay
(ELISA) kits for human collagen I (Col I), collagen II
(Col III), and fibronectin (FN) were from RB (Boston,
MA, USA). Rat anti-human α-smooth muscle actin
(α-SMA) polyclonal antibodies were from Abcam
(New Territories, Hong Kong). Rabbit anti-human
E-cadherin polyclonal antibodies, were from Cell Sig-
naling. Kits for immunohistochemical detection were
from Beijing Zhongsan Jinqiao Biotechnology Co.,
Ltd. (BeiJing, China). Human recombinant TGF-β1
was purchased from R and D Systems (Emeryville,
CA, USA). In accordance with the manual, human re-
combinant TGF-β1 was prepared as a stock solution of
1 μg/mL with aseptic weak HCL (4 mM) and bovine
serum albumin of 1 mg/mL. TGF-β1 was kept in asep-
tic EP tubes at －70℃ and was prepared as 10 ng/mL
at use.6
Tangnaikang granules were supplied by Beijing Univer-
sity of Traditional Chinese Medicine and were com-
posed of Renshen (Radix Ginseng), Nüzhenzi (Fructus
Ligustri Lucidi), Xiakucao (Spica Prunellae Vulgaris),
Sanbaicao (Herba Saururi), and Fanshiliuye (Folium Ea-
calypti Robustae). The powder of each gram contained
3.61 g crude drugs, and the clinical dosage for adults
was 54.15 g, corresponding to 0.9025 g (crude drugs)/kg.
Instruments
A CO2 incubator, Heal HF90, was from Li Kang (HK,
China). A biological safety cabinet, Esco Class II BSC,
was from Airstream (Singapore). An inverted micro-
scope, Olympus X-71, was from Olympus (Tokyo, Ja-
pan). The ELISA plate reader used was a CliniBio
128L-400 (Austria).
Preparation of Tangnaikang serum
Twenty-four Wistar rats, male, SPF grade, were fed in
the Animal Experimental Room (barrier grade), Gener-
al Hospital of Lanzhou Military Region (license No:
SYXK-[Army] 2007-022) with a common forage. Rats
were randomly divided into two groups, a blank group
and a Tangnaikang group, and there were 12 rats in
each group. The rats in the Tangnaikang group were in-
tragastrically administrated Tangnaikang at a 10-fold
clinical dosage compared with that of of adults. The
blank group was given the same volume of saline as
that the Tangnaikang group. Each treatment was 1 mL/
100 g body weight/time, once in the morning and the
afternoon, every 12 h, for 3 consecutive days. The rats
were fasted with free access to water 8 h before the last
intragastric administration. thirty minutes later, blood
was taken by the aseptic method from the femoral ar-
tery, kept for 2 h, and centrifuged at 3000 rpm at 4℃
for 20 min. The supernatant was mixed with those of
the same group, inactivated in a water bath at 56℃ for
30 min, and kept at－20℃ until use.
Culture and grouping of cells
HK-2 cells were cultured by DMEM/F12 (1∶1) com-
plete medium with 10% fetal calf serum, 100 U/mL
penicillin and 100 μg/mL streptomycin in a cell incu-
bator with 5% CO2 at 37℃ . The culture medium was
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changed with fresh medium at an interval of 2-3 days.
When the culture confluence reached over 80%, it was
digested with 0.25% trypsin and 0.05% ethylene di-
amine tetraacetic acid (EDTA). After digestion was
stopped with complete culture medium, it was centri-
fuged for 5 min (1000 rpm). After the cells were again
suspended with fresh culture medium, a subculture
was carried out. Before the experiment, the cells were
cultured with serum-free medium for 24 h, making a
synchronized culture, which was repeated thrice.
HK-2 subcultured cells were divided into six groups:
(a) blank control group: DMEM/F12 culture medium;
(b) TGF-β group: DMEM/F12 culture medium +
10 ng/mL TGF-β1; (c) blank serum control group:
DMEM/F12 culture medium + 10 ng/mL TGF-β1 +
10% blank serum; (d) treatment group 1: DMEM/
F12 culture medium+10 ng/mL TGF-β1+5% Tangnai-
kang serum; (e) treatment group 2: DMEM/F12 cul-
ture medium+10 ng/mL TGF-β1+10% Tangnaikang se-
rum; and (f ) treatment group 3: DMEM/F12 culture
medium+10 ng/mL TGF-β1+20% Tangnaikang serum.
Detection of α-SMA and E-cadherin expression with
a cellular immunochemical method
After sterilization, the coverglass was placed on a
24-well plate, and 0.1 mg/mL aseptic poly-L-lysine
was added for coating for 5 min. Then, the poly-L-ly-
sine was vacuumed, thoroughly rinsed with aseptic wa-
ter, air-dried, radiated with ultraviolet light for 20 min,
and preserved. The cells (2×104 cells/mL) were inoculat-
ed, 1 mL was added to each well, and they were incu-
bated for 24 h. The supernatant was vacuumed off,
and 1 mL serum-free medium was added and allowed
to sit for 24 h, making a synchronous culture. The su-
pernatant was removed and medium containing the
corresponding concentration of drug was added, 1 mL
in each well, for 24 h. The cell plate was taken out and
rinsed with 0.01 M PBS for 5 min three times. Cell
plates were fixed with 4% paraformaldehyde for 20 min
and stored at－20℃ until use.
For staining with the cellular immunochemical meth-
od, the cell plate was first incubated with 3% H2O2 de-
ionized water (colorless liquid) at room temperature
for 10 min to inactivate endogenous peroxidase. After
rinsing with distilled water and washing with PBS for
5 min, the antigen was prepared in the microwave and
incubated with normal goat serum at room tempera-
ture for 10-15 min for blocking non-specific combin-
ing sites. Then, the proper ratios of mouse anti-humanα-SMA poly-colonic antibody or rabbit anti-human
E-cadherin poly-colonic antibody, were incubated on
the plates overnight at 4℃ . The next day, plates were
taken out and washed with PBS for 3 min three times
at room temperature. Plates were then incubated with
secondary antibody and ABC reagent for 15 min suc-
cessively. Finally, cells were colored with DAB, counter
stained with hematoxylin, dehydrated with alcohol,
and mounted with neutral resin. Cellular morphology
was observed with a microscope and photographed.
The pale brown sections of the photographs indicate
positive expression part of antigen.
Detection of cellular proliferation with an MTT
method
Cells (3×104/mL) were placed in a 96-well plate, 100 μL
in each well, five wells per group, and incubated over-
night at 37℃ , 5% CO2. After the supernatant was re-
moved, 100 μL serum-free medium was added for 24 h,
making a synchronous culture. The cellular superna-
tant was removed and then 100 μL of the correspond-
ing drug was added, with 100 μL medium added in
the control group. One plate each at 24, 48, and 72 h
was taken, the culture supernatant was removed, and
100 μL 1 mg/mL MTT was added and incubated for
4 h. The supernatant was removed and 100 μL
DMSO was added to each well with one well as a
blank. Vibration for 10 min then dissolved the blue-vi-
olet crystals completely. Absorbance values at 492 nm
were read in an ELISA reader.
Detection of Col I, Col II and FN with ELISA
Cells (2 × 104 cells/mL) were inoculated in a 24-well
plate, 1 mL in each well with two wells per each group,
and cultured overnight. The supernatant was then re-
moved and 1 mL serum-free culture liquid was added
for 24 h, to make a synchronous culture. After the su-
pernatant was removed, 1 mL of culture liquid contain-
ing the corresponding concentration of drug was add-
ed to each well. The supernatant was collected at 24, 48,
and 72 h, centrifuged at 4℃ for 20 min (2000 rpm),
and kept at－20℃ until detection, following the direc-
tions of the ELISA kits. The supernatant was removed
and 100 μL of standard samples or detected samples of
different concentrations were added to each well on
the coating reaction strip. 100 μL diluted solution was
added to the blank control well, incubated at 37℃ ,
rinsed, and the reaction was stopped with ELISA anti-
body. The OD value of each well was detected at 450
nm in the ELISA reader with the blank control regulat-
ed as zero. Concentrations of samples were then calcu-
lated.
Statistical analysis
SPSS 13.0 software (SPSS, Chicaga, IL, USA) was
used for one-way ANOVA analysis, and the data were
expressed as mean±standard deviation ( xˉ ± s), P<0.05
was regarded as statistical significance.
RESULTS
Effect of TNK on phenotype transdifferentiation of
the HK-2 cell
Cellular immunochemical detection indicated that nor-
mal cells showed ovoid or cuboid forms, and grew in a
sheet with close intercellular connections. On the cellu-
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lar membrane, there was a strong expression of E-cad-
herin and almost no α-SMA expression. After TGF-β1
administration, the cellular form changed significantly.
Cells exhibited a spindle form with an intracellular
space similar to fibroblast growth. Expression ofα-SMA was strong in the cytoplasm and E-cadherin ex-
pression almost disappeared. After administration with
a high concentration of Tangnaikang serum, α-SMA
expression was significantly reduced and E-cadherin ex-
pression clearly increased, while the blank serum did
not have similar effects (Figure 1, 2).
Effect of TNK on proliferation of HK-2 cells
MTT detection showed that after introduction of
TGF-β1, the HK-2 cells had significantly greater prolif-
eration than the blank control group cells (P<0.05).
Proliferation was time-dependent and after addition of
Tangnaikang serum, the cell proliferation was inhibited
(P<0.05) dose-dependently. Blank serum did not have
similar effects (Table 1).
Effects of TNK on secretions of Col I, Col III, and FN
in HK-2 cells
ELISA detection indicated that 24, 48, and 72 h after
treatment with TGF-β1, secretions of Col I, Col III,
and FN in HK-2 cells significantly increased time-de-
pendently compared with the blank control group (P<
0.05). After addition of Tangnaikang serum, secretions
of Col I, Col III, and FN gradually reduced dose-de-
pendently (P<0.05). The blank serum control did not
have the same effects (Tables 2-4).
DISCUSSION
Recent studies on fibrosis have indicated that pheno-
type transdifferentiation of renal tubular epithelial cells
is closely correlated with the course of renal interstitial
fibrosis. Phenotype transdifferentiation, or dedifferenti-
ation, occurs when a certain cell type loses its specific
phenotype characteristics and gains other phenotype
characteristics in response to environmental changes.
Research indicates that renal tubular epithelial cells can
show phenotype transdifferentiation in response to in-
flammation, damage, acute ischemia, degeneration,
and necrosis.7
The mechanism of transdifferentiation in renal tubular
epithelial cells is not yet clear. At present, it is thought
that renal tubular epithelial cell transdifferentiation in-
to myofibroblasts is one of the mechanisms of the for-
mation of renal interstitial fibrosis.8 Myofibroblasts are
the main cells that synthesize extracellular matrix in
CBA D
Figure 2 Effect of Tangnaikang serum on E-cadherin expression (Immunocytochemistry staining, ×20)
A: blank control group; B: TGF-β1group; C: serum control group; D: treatment group 3.
Table 1 Effect of TNK on proliferation of HK-2 cells (A492nm, xˉ ±s)
Group
Blank control group
TGF-β1 group
Serum control group
Treatment group 1
Treatment group 2
Treatment group 3
n
6
6
6
6
6
6
24 h
0.247±0.004a
0.287±0.005b
0.284±0.003b
0.281±0.005b
0.269±0.006ab
0.253±0.004a
48 h
0.291±0.004a
0.343±0.009b
0.346±0.008b
0.343±0.003b
0.326±0.004ab
0.320±0.005ab
72 h
0.311±0.005a
0.360±0.005b
0.356±0.004b
0.348±0.005ab
0.332±0.010ab
0.320±0.004a
Notes: HK-2: Human renal tubular epithelial cell line; TNK: Tangnaikang; TGF-β1: transforming growth factor-β1. Compared with the
blank control group, bP<0.05; compared with the TGF-β1 group, aP<0.05.
B C D
Figure 1 Effect of Tangnaikang serum on α-SMA expression (Immunocytochemistry staining, ×20)
A: blank control group; B: TGF-β1 group; C: serum control group; D: treatment group 3. α-SMA: α-smooth muscle actin.
A
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the mesenchyme, and an increase in the extracellular
matrix directly leads to progressive development of re-
nal fibrosis. The source of myofibroblasts is not clear,
but in recent years it has been found that a consider-
able portion originates from renal tubular epithelial
cells, in addition to activation of fibroblasts. During
the course of renal fibrosis, 36% of newly increased fi-
brocytes originate from transdifferentiation of renal tu-
bular epithelial cells. The characteristics of phenotype
transdifferentiation include changes of renal tubular ep-
ithelial cells in form, phenotype, and function. First,
the adhesion between renal tubular epithelial cells dis-
appears, and then a marker protein of myofibroblasts,α-SMA, is expressed. Meanwhile, the marker protein
of the epithelial cells, E-cadherin, is barely expressed.
Along with destruction of the structure of the tubular
basement membrane, the cells finally migrate and infil-
trate the interstitial action site to secret basement pro-
teins, leading to formation of fibrosis.9
Some studies indicate that cytokines and metabolites
can participate in the transdifferentiation of renal tubu-
lar epithelial cells. Most study focuses on TGF-β,
which is greatly expressed and secreted in many chron-
ic renal diseases. TGF-β is generally recognized as the
most important cytokine inducing transdifferentiation
of epithelial cells, and other many cytokines influence
transdifferentiation of epithelial cells through regulat-
ing production of TGF-β.10 Fan et al 7 studied the ef-
fect of TGF-β on renal tubular epithelial cells in the
mouse and found that the percentage of TEC cells ex-
Table 2 Effect of TNK on secretion of Col I in HK-2 cells (ng/mL, xˉ ±s)
Group
Blank control group
TGF-β1 group
Serum control group
Treatment group 1
Treatment group 2
Treatment group 3
n
3
3
3
3
3
3
24 h
165.0±4.8a
196.4±2.5b
196.8±6.8b
193.6±2.2b
186.4±2.8b
175.6±3.0a
48 h
177.4±2.7a
200.5±7.0b
198.0±2.8b
196.3±2.3b
188.3±5.4
182.5±1.8a
72 h
186.5±2.6a
217.4±2.0b
215.2±3.5b
207.4±2.8b
195.8±2.1a
191.2±5.4a
Notes: HK-2: Human renal tubular epithelial cell line; TNK: Tangnaikang; TGF-β1:transforming growth factor-β1. Compared with the
blank control group, bP<0.05; compared with the TGF-β1 group, aP<0.05.
Table 3 Effect of TNK on secretion of Col III in HK-2 cells (ng/mL, xˉ ±s)
Group
Blank control group
TGF-β1 group
Serum control group
Treatment group 1
Treatment group 2
Treatment group 3
n
3
3
3
3
3
3
24 h
23.65±1.23a
32.35±1.03b
32.46±0.88b
31.81±0.83b
28.15±0.86ab
26.40±0.38ab
48 h
27.60±1.24a
35.10±0.41b
35.39±0.97b
34.17±0.74b
32.14±0.84ab
30.09±0.14a
72 h
30.74±0.89a
38.30±0.33b
38.70±0.11b
37.97±0.72b
34.82±1.02ab
32.26±0.53a
Notes: HK-2: Human renal tubular epithelial cell line; TNK: Tangnaikang; TGF-β1:transforming growth factor-β1. Compared with the
blank control group, bP<0.05; compared with the TGF-β1 group, aP<0.05.
Table 4 Effect of TNK on secretion of FN in HK-2 cells (ng/mL, xˉ ±s)
Group
Blank control group
TGF-β1 group
Serum control group
Treatment group 1
Treatment group 2
Treatment group 3
n
3
3
3
3
3
3
24 h
841.5±7.4a
918.9±2.5b
917.8±8.5b
904.9±4.0b
880.4±9.9ab
851.9±4.9a
48 h
872.6±3.6a
947.8±6.6b
949.1±7.7b
945.4±7.7b
926.8±8.9b
897.7±9.3ab
72 h
921.8±5.7a
975.4±8.5b
984.2±7.5b
978.6±7.5b
960.6±7.0b
930.6±6.2a
Notes: HK-2: Human renal tubular epithelial cell line; TNK: Tangnaikang; TGF-β1: transforming growth factor-β1. Compared with the
TGF-β1 group, aP<0.05; compared with the blank control group, bP<0.05.
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pressing α-SMA increases along with increases in
TGF-β dosage. However, the cells expressing E-cad-
herin completely disappear after culturing for 6 days in
TGF-β at 50 ng/mL. Yang et al 10 reported that in a
one-sided ureteral obstruction model, TGF-β1 induces
the transdifferentiation of epithelial cells. They found
that TGF-β1 participates in the whole course of trans-
differentiation. TGF-β1 from 2-10 ng/mL can induce
transdifferentiation of renal tubular epithelial cells cul-
tured in vitro.6
In the present study, we found that normal HK-2 cells
are ovoidal or cuboidal and do not express α-SMA, but
do express E-cadherin, a marker of epithelial cells. Af-
ter stimulation with TGF-β1 at 10 ng/mL, HK-2 cells
showed hypertrophy, a long spindle form, and a de-
crease in number. Immunocellular chemical staining in-
dicated that many cells highly express the myofibro-
blast marker, α-SMA, and expression of E-cadherin al-
most disappears. This shows that HK-2 cells demon-
strate obvious phenotype transdifferentiation under the
action of TGF-β1, which agrees with previous reports.
Secretions of extracellular matrix components, Col I,
Col III, and FN, also significantly increased. Sedimen-
tation of extracellular matrix components is a main
characteristic of fibrosis. However, after addition of in-
creasing concentrations of Tangnaikang serum, the ex-
pression of α-SMA was gradually inhibited and the ex-
pression of E-cadherin was gradually restored. More-
over, secretions of Col I, Col III, and FN were gradual-
ly reduced, indicating that Tangnaikang ameliorates re-
nal fibrosis possibly by inhibiting transdifferentiation
of renal tubular epithelial cells.
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